Perspective on the role of Ozurdex (dexamethasone intravitreal implant) in the management of diabetic macular oedema

Therapeutic Advances in Chronic Disease
Hemal MehtaSamantha Fraser-Bell

Abstract

Diabetic macular oedema (DMO) is the most common cause of visual loss in the working age population. Intravitreal therapy has superseded macular laser as the first-line treatment for the management of centre-involving DMO in most patients. As well as the proven efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents, phase II and III clinical trials of Ozurdex intravitreal dexamethasone implants for DMO have also demonstrated a mean increase in visual acuity and corresponding mean reduction in central macular thickness, particularly in pseudophakic eyes. Because of the risk of visual loss from cataract, glaucoma and intraocular infection with the use of intravitreal steroids, Ozurdex tends to be reserved for use in patients unresponsive to anti-VEGF therapy for centre-involving DMO. Situations where Ozurdex may be considered a first-line treatment option for eyes with centre-involving DMO include pseudophakia, impending cataract surgery, or in the context of a recent arterial thromboembolic event. Because of their stable pharmacokinetics, Ozurdex slow-release implants may also be considered in vitrectomized eyes.

References

Jun 17, 1998·Ophthalmology·S E MossB E Klein
Nov 10, 2004·Archives of Ophthalmology·David R MatthewsUNKNOWN UK Prospective Diabetes Study Group
Dec 14, 2005·Ophthalmology·Anthony P AdamisUNKNOWN Macugen Diabetic Retinopathy Study Group
Jun 23, 2007·The British Journal of Ophthalmology·S M HariprasadL Miller
Jul 3, 2007·American Journal of Ophthalmology·Ates YanyaliAhmet F Nohutcu
Aug 15, 2009·Acta Ophthalmologica·Giuseppe QuerquesNicola D Noci
Apr 30, 2010·Ophthalmology·UNKNOWN Diabetic Retinopathy Clinical Research NetworkJennifer K Sun
Apr 14, 2011·Retina·David S BoyerUNKNOWN Ozurdex CHAMPLAIN Study Group
Oct 1, 2011·Journal of Ophthalmic Inflammation and Infection·Reema BansalAmod Gupta
Nov 15, 2011·Diabetes Research and Clinical Practice·David R WhitingJonathan Shaw
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Feb 15, 2012·Ophthalmology·Quan Dong NguyenUNKNOWN RISE and RIDE Research Group
Apr 28, 2012·Ophthalmology·Diana V DoUNKNOWN da Vinci Study Group
Jun 20, 2012·American Journal of Ophthalmology·Tien Yin WongPaul Mitchell
Feb 14, 2013·Investigative Ophthalmology & Visual Science·Hiroki OtsukaTaiji Sakamoto
Aug 24, 2013·Survey of Ophthalmology·Christine A KiireVictor Chong
Nov 13, 2013·Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus·Miguel Cordero-ComaJosé G Ruíz de Morales
Feb 13, 2014·European Journal of Ophthalmology·Javier Coca-RobinotJesús García-Martínez
Mar 22, 2014·The British Journal of Ophthalmology·Rupesh AgrawalPeter K F Addison
Apr 29, 2014·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Matthew P SimunovicI-Van Ho
May 8, 2014·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Carsten H MeyerUNKNOWN German Retinal Vein Occlusion Group
May 9, 2014·Ophthalmic Surgery, Lasers & Imaging Retina·Alexander M EatonRobert L Avery
May 13, 2014·Journal français d'ophtalmologie·S GuigouF Meyer
May 24, 2014·Current Diabetes Reviews·Pedro Romero-ArocaCristina Blasco-Suñe
Feb 19, 2015·The New England Journal of Medicine·UNKNOWN Diabetic Retinopathy Clinical Research NetworkRoy W Beck

❮ Previous
Next ❯

Citations

Jan 20, 2016·Ophthalmology·Samantha Fraser-BellMark C Gillies
Sep 3, 2017·British Journal of Pharmacology·Sahar AwwadAlastair Lockwood
May 17, 2019·Expert Opinion on Drug Delivery·Francine Behar-Cohen
Nov 21, 2017·Retinal Cases & Brief Reports·Kapil G Kapoor, James B Colchao
May 24, 2020·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Sahar AwwadSteve Brocchini
Jun 15, 2020·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Russell MacoonAnuj Chauhan
Apr 4, 2021·Biomedicines·Natallia V DubashynskayaYury A Skorik

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT01492400
NCT01546402
NCT01787669

Software Mentioned

TDMO
DRCRnet

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.